TAG
PRNewswire
Everest Medicines' Partner Calliditas Therapeutics Announces Nefecon® the Only FDA-approved Treatment for IgA Nephropathy to Significantly Slow Kidney Function Decline
SHANGHAI, Dec. 21, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company")'s licensing partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX)...
Explore AsiaRF's Wireless Innovations at CES 2024, Las Vegas: Tech Excellence Unveiled.
TAIPEI, Dec. 21, 2023 /PRNewswire/ -- AsiaRF, a global leader in wireless connectivity, is thrilled to announce its participation in CES 2024, the world's...
BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a...
WUXI, China, Dec. 21, 2023 /PRNewswire/ -- BioCity Biopharma today announced dosing of the first patient in a Phase Ib/II clinical trial of its...
DEEPX Making High-Performance, Low-Power AI Servers A Reality with DX-H1 Launch at CES 2024
The award-winning AI booster achieves over 10 times power-to-performance efficiency compared to GPUs LAS VEGAS, Dec. 21, 2023 /PRNewswire/ -- DEEPX (CEO, Lokwon...
